Martin C. Cherrier
Centre National de la Recherche Scientifique(FR)École Nationale Supérieure d'Ingénieurs de Caen(FR)Normandie Université(FR)GREYC(FR)Université de Caen Normandie(FR)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Neurotransmitter Receptor Influence on Behavior, Inflammatory mediators and NSAID effects
Most-Cited Works
- → 3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice(2008)93 cited
- → 1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of the Human Orphan G-Protein-Coupled Receptor GPR109b(2006)80 cited
- → (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans(2012)51 cited
- → Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a(2007)36 cited
- → Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)(2010)32 cited
- → Agonist lead identification for the high affinity niacin receptor GPR109a